Medicxi Ventures Management (Jersey) Ltd
Net seller this quarter
$177M
3
-$809M
100.0%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 PHAT | $81M | 45.65% | 9.32% | Not reported | Q4 2019 |
 NAMS | $74.9M | 42.19% | 1.88% | -17.4% | Q4 2022 |
 AURA | $21.6M | 12.16% | 2.94% | Not reported | Q4 2021 |
| Q1 2026 | |||||
| CNTA | $793M | 80.76% | 12.90% | Not reported | Q2 2021 |
| NAMS | $85.6M | 8.72% | 2.29% | -6.8% | Q4 2022 |
| PHAT | $82.9M | 8.45% | 9.40% | Not reported | Q4 2019 |
| AURA | $20.3M | 2.07% | 4.74% | Not reported | Q4 2021 |
| Q4 2025 | |||||
| CNTA | $499M | 59.80% | 13.38% | Not reported | Q2 2021 |
| PHAT | $124M | 14.83% | 10.45% | Not reported | Q4 2019 |
| NAMS | $101M | 12.06% | 2.51% | Not reported | Q4 2022 |
| RAPT | $94.6M | 11.33% | 10.08% | Not reported | Q4 2024 |
| AURA | $16.6M | 1.98% | 4.78% | Not reported | Q4 2021 |
| Q3 2025 | |||||
| CNTA | $484M | 65.03% | 14.85% | Not reported | Q2 2021 |
| PHAT | $87.9M | 11.80% | 10.51% | Not reported | Q4 2019 |
| NAMS | $81.6M | 10.96% | 2.54% | Not reported | Q4 2022 |
| RAPT | $72.1M | 9.68% | 16.89% | Not reported | Q4 2024 |
| AURA | $18.8M | 2.52% | 4.83% | Not reported | Q4 2021 |